牛牛AI助理已提取核心訊息
On December 31, 2023, Armistice Capital, LLC and its managing member Steven Boyd filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a 6.71% ownership stake in Tonix Pharmaceuticals Holding Corp., amounting to 3,770,000 shares. The filing indicates that Armistice Capital, LLC, a Delaware-based investment adviser, and Steven Boyd, a U.S. citizen, share voting and dispositive power over these shares. The shares are held by the Master Fund, which is managed by Armistice Capital under an Investment Management Agreement. The Master Fund is an investment advisory client of Armistice Capital and is entitled to dividends or sale proceeds from the securities. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
On December 31, 2023, Armistice Capital, LLC and its managing member Steven Boyd filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a 6.71% ownership stake in Tonix Pharmaceuticals Holding Corp., amounting to 3,770,000 shares. The filing indicates that Armistice Capital, LLC, a Delaware-based investment adviser, and Steven Boyd, a U.S. citizen, share voting and dispositive power over these shares. The shares are held by the Master Fund, which is managed by Armistice Capital under an Investment Management Agreement. The Master Fund is an investment advisory client of Armistice Capital and is entitled to dividends or sale proceeds from the securities. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
2023年12月31日，停戰資本有限責任公司及其管理成員史蒂芬·博伊德向美國證券交易委員會提交了附表13G，披露了Tonix Pharmicals Holding Corp. 6.71％的所有權，總額爲3,77萬股。該文件顯示，駐特拉華州的投資顧問Armistice Capital, LLC和美國公民史蒂芬·博伊德共享對這些股票的投票權和處置權。這些股票由主基金持有，該基金由停戰資本根據投資管理協議進行管理。萬事達基金是停戰資本的投資諮詢客戶，有權從證券中獲得股息或出售收益。該文件稱，這些股票是在正常業務過程中收購的，不是爲了改變或影響發行人的控制權。
2023年12月31日，停戰資本有限責任公司及其管理成員史蒂芬·博伊德向美國證券交易委員會提交了附表13G，披露了Tonix Pharmicals Holding Corp. 6.71％的所有權，總額爲3,77萬股。該文件顯示，駐特拉華州的投資顧問Armistice Capital, LLC和美國公民史蒂芬·博伊德共享對這些股票的投票權和處置權。這些股票由主基金持有，該基金由停戰資本根據投資管理協議進行管理。萬事達基金是停戰資本的投資諮詢客戶，有權從證券中獲得股息或出售收益。該文件稱，這些股票是在正常業務過程中收購的，不是爲了改變或影響發行人的控制權。
有用
沒用